Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions

被引:228
作者
Iwakiri, Yasuko [1 ]
Shah, Vijay [2 ]
Rockey, Don C. [3 ]
机构
[1] Yale Univ Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Pericyte; Sinusoid; Pressure; Resistance; Therapy; NITRIC-OXIDE SYNTHASE; SINUSOIDAL ENDOTHELIAL-CELLS; PORTAL HYPERTENSIVE-RATS; HEPATIC STELLATE CELLS; SCANNING ELECTRON-MICROSCOPE; FIBROBLAST-GROWTH-FACTOR; FARNESOID X RECEPTOR; SMOOTH MUSCLE ACTIN; IN-VIVO; GENE-TRANSFER;
D O I
10.1016/j.jhep.2014.05.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is associated with remarkable alterations in the intra- and extrahepatic vasculature. Because of these changes, the fields of liver vasculature and portal hypertension have recently become closely integrated within the broader vascular biology discipline. As developments in vascular biology have evolved, a deeper understanding of vascular processes has led to a better understanding of the mechanisms of the dynamic vascular changes associated with portal hypertension and chronic liver disease. In this context, hepatic vascular cells, such as sinusoidal endothelial cells and pericyte-like hepatic stellate cells, are closely associated with one another, where they have paracrine and autocrine effects on each other and themselves. These cells play important roles in the pathogenesis of liver fibrosis/cirrhosis and portal hypertension. Further, a variety of signaling pathways have recently come to light. These include growth factor pathways involving cytokines such as transforming growth factor beta, platelet derived growth factor, and others as well as a variety of vasoactive peptides and other molecules. An early and consistent feature of liver injury is the development of an increase in intra-hepatic resistance; this is associated with changes in hepatic vascular cells and their signaling pathway that cause portal hypertension. A critical concept is that this process aggregates signals to the extrahepatic circulation, causing derangement in this system's cells and signaling pathways, which ultimately leads to the collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulation, which by virtue of the hydraulic derivation of Ohm's law (pressure = resistance x flow), worsens portal hypertension. This review provides a detailed review of the current status and future direction of the basic biology of portal hypertension with a focus on the physiology, pathophysiology, and signaling of cells within the liver, as well as those in the mesenteric vascular circulation. Translational implications of recent research and the future directions that it points to are also highlighted. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:912 / 924
页数:13
相关论文
共 130 条
[1]   Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state [J].
Abraldes, JG ;
Iwakiri, Y ;
Loureiro-Silva, M ;
Haq, O ;
Sessa, WC ;
Groszmann, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (05) :G980-G987
[2]   Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats [J].
Abraldes, Juan G. ;
Rodriguez-Vilarrupla, Aina ;
Graupera, Mariona ;
Zafra, Carmen ;
Garcia-Caldero, Hector ;
Garcia-Pagan, Juan Carlos ;
Bosch, Jaime .
JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1040-1046
[3]   Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial [J].
Abraldes, Juan G. ;
Albillos, Agustin ;
Banares, Rafael ;
Turnes, Juan ;
Gonzalez, Rosario ;
Garcia-Pagan, Juan Carlos ;
Bosch, Jaime .
GASTROENTEROLOGY, 2009, 136 (05) :1651-1658
[4]  
ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957
[5]   VEGF Trap for the treatment of malignant ascites [J].
Becker, Gerhild ;
Blum, Hubert E. .
LANCET ONCOLOGY, 2012, 13 (02) :115-116
[6]  
BHUNCHET E, 1993, HEPATOLOGY, V18, P1450
[7]   Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats [J].
Bolognesi, Massimo ;
Zampieri, Francesca ;
Di Pascoli, Marco ;
Verardo, Alberto ;
Turato, Cristian ;
Calabrese, Fiorella ;
Lunardi, Francesca ;
Pontisso, Patrizia ;
Angeli, Paolo ;
Merkel, Carlo ;
Gatta, Angelo ;
Sacerdoti, David .
LIVER INTERNATIONAL, 2011, 31 (06) :883-892
[8]   MYOFIBROBLASTS AND SUBEPITHELIAL FIBROSIS IN BRONCHIAL-ASTHMA [J].
BREWSTER, CEP ;
HOWARTH, PH ;
DJUKANOVIC, R ;
WILSON, J ;
HOLGATE, ST ;
ROCHE, WR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (05) :507-511
[9]   Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance [J].
Burri, PH ;
Hlushchuk, R ;
Djonov, V .
DEVELOPMENTAL DYNAMICS, 2004, 231 (03) :474-488
[10]   SCANNING ELECTRON-MICROSCOPE STUDY OF THE DEVELOPING MICROVASCULATURE IN THE POSTNATAL RAT LUNG [J].
CADUFF, JH ;
FISCHER, LC ;
BURRI, PH .
ANATOMICAL RECORD, 1986, 216 (02) :154-164